Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis

Published:2012-06 Issue:6 Volume:10 Page:651-656
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Corey Kathleen E.,Lai Michelle,Gelrud Louis G.,Misdraji Joseph,Barlow Lydia L.,Zheng Hui,Andersson Karin L.,Thiim Michael,Pratt Daniel S.,Chung Raymond T.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study;Dunn;Am J Gastroenterol,2008

2. Nonalcoholic fatty liver disease in severely obese subjects;Gholam;Am J Gastroenterol,2007

3. Hepatic histology in obese patients undergoing bariatric surgery;Machado;J Hepatol,2006

4. Long-term follow-up of patients with NAFLD and elevated liver enzymes;Ekstedt;Hepatology,2006

5. Liver biopsy;Rockey;Hepatology,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis;Biomarker Research;2024-01-09

2. Phenotypic and Metabolomic Characteristics of Mouse Models of Diet-Induced Hepatic Steatosis;2023-10-06

3. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology;Medicine;2022-10-28

4. Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial;European Journal of Gastroenterology & Hepatology;2021-12-03

5. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet;Nutrients;2021-02-12